Medical devices including functionalized polymers and related methods

Patent metadata

Field	Value
Publication number	US-11285245-B2
Application number	US-201916270343-A
Country	US
Kind code	B2
Filing date	Feb 7, 2019
Priority date	Feb 9, 2018
Publication date	Mar 29, 2022
Grant date	Mar 29, 2022

Abstract

Medical devices that are formed from a polymeric matrix including a first polymer and a functionalized polymer are provided. The medical devices may include a functionalized polymer such as maleic anhydride functionalized polymer. The burst strength and/or the hoop strength of the medical devices including the functionalized polymer may be greater than the burst strength and/or the hoop strength of control medical devices. However, the durometer of the medical devices may be substantially equal to the durometer of the control medical devices. Methods of manufacturing medical devices including a functionalized polymer are also provided.

First claim

The invention claimed is:

1. An extruded medical device comprising:
an elongate body formed from a polymeric matrix comprising:
a first polymer, wherein the first polymer is selected from at least one of polyurethane, polyether block amide, or nylon; and
a maleic anhydride functionalized polymer, wherein the maleic anhydride functionalized polymer is maleic anhydride polypropylene (MAPP), wherein the weight-to-weight ratio of the maleic anhydride functionalized polymer in the polymeric matrix is between 0.5 wt % and 8 wt %, wherein the degree of functionalization of the maleic anhydride functionalized polymer is between about 0.5 wt % and about 5 wt %; and

a lumen extending through a portion of the elongate body,
wherein the burst strength/hoop strength of a portion of the extruded medical device is increased between about 25 psi and about 100 psi when compared to a control extruded medical device lacking the maleic anhydride functionalized polymer.

2. The extruded medical device of claim 1 , wherein the first polymer is configured to form hydrogen bonds with the maleic anhydride functionalized polymer.

3. The extruded medical device of claim 1 , wherein the extruded medical device is a catheter or a balloon.

4. The extruded medical device of claim 1 , wherein the durometer of a portion of the extruded medical device is between about 78 A and about 102 A.

5. The extruded medical device of claim 1 , wherein the polymer of the maleic anhydride functionalized polymer is selected from at least one of polyethylene, polypropylene, polyamide, polyethylene terephthalate, syndiotactic polystyrene, polyphenyl ether, ethylene-vinyl acetate, polyethylene glycol, ethylene propylene diene, ethylene butyl acrylate, cellulose, or hydrogenated poly-isoprene/butadiene.

6. The extruded medical device of claim 1 , further comprising a radiopaque agent.

7. The extruded medical device of claim 6 , wherein the radiopaque agent is selected from at least one of barium sulfate, bismuth trioxide, bismuth subcarbonate, bismuth oxychloride, or tungsten.

8. The extruded medical device of claim 6 , wherein the weight-to-weight ratio of the radiopaque agent in the polymeric matrix is between about 10% and about 40%.

Assignees

• Bard Inc C R

Inventors

• Mcfarland Todd
• Freasier James
• Francis Aaron
• Jackson Colton

Classifications

• A61L29/041 Primary

  obtained by reactions only involving carbon-to-carbon unsaturated bonds · CPC title

• A61L29/18

  Materials at least partially X-ray or laser opaque · CPC title

• A61L31/127 Primary

  containing fillers of phosphorus-containing inorganic materials · CPC title

• A61L29/06

  obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds · CPC title